Related Experiment Video
Updated: Mar 3, 2026
09:33
Rapid Isolation of the Mitoribosome from HEK Cells
Published on: October 4, 2018
11.8K
Mitochondrial ribosomes in cancer
Hyun-Jung Kim1, Priyanka Maiti2, Antoni Barrientos3
1Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, USA.
Seminars in Cancer Biology
|April 27, 2017
Summary
Mitochondrial ribosomes (mitoribosomes) are crucial for cellular respiration and apoptosis. Their altered expression in cancer suggests they are key targets for new cancer therapies.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Mitochondria are vital for cellular energy production via oxidative phosphorylation (OXPHOS) and regulate apoptosis.
- Mitochondria contain their own genome (mtDNA) and protein synthesis machinery, including specialized ribosomes (mitoribosomes).
- Mitoribosomes synthesize proteins essential for OXPHOS and cellular respiration.
Purpose of the Study:
- To review the dual role of mitoribosome components in protein synthesis and apoptosis.
- To explore the association between mitoribosome function and cancer susceptibility and development.
- To highlight novel therapeutic strategies targeting mitoribosomes in cancer treatment.
Main Methods:
- Literature review of current research on mitoribosomes.
- Analysis of studies investigating mitoribosome gene expression in various cancers.
- Examination of evidence linking mitoribosome function to tumorigenesis and metastasis.
Main Results:
- Mitoribosome proteins have a dual function: essential for OXPHOS and capable of inducing apoptosis.
- Altered expression of mitoribosome-related genes is frequently observed in cancers.
- These alterations are linked to cancer initiation, progression, and metastasis.
Conclusions:
- Mitoribosomes play a critical role in both normal cellular functions and cancer development.
- Targeting mitoribosomes presents a promising avenue for novel cancer therapies.
- Further research into mitoribosome regulation could unlock new treatment strategies.
More Related Videos
Related Concept Videos
02:55The Nucleolus
10.5K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.5K
01:46Electron Transport Chain: Complex I and II
19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:19Translocation of Proteins into the Mitochondria
13.6K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.6K
01:39Mitochondrial Precursor Proteins
3.9K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
3.9K